RhCG is downregulated in oesophageal squamous cell carcinomas, but expressed in multiple squamous epithelia

European Journal of Cancer

Volumn 38, Issue 14, 2002, Pages 1927-1936

  Chen, Bao Sheng ^a   Xu, Zhi Xiong ^a   Xu, Xin ^a   Cai, Yan ^a   Han, Ya Ling ^a   Wang, Jie ^a   Xia, Shu Hua ^a   Hu, Hai ^a   Wei, Fang ^a   Wu, Min ^a   Wang, Ming Rong ^a  

^a CANCER HOSPITAL   (China)

Author keywords

Downregulation; Oesophageal squamous cell carcinoma; RhCG; Squamous epithelia

Indexed keywords

GLYCOPROTEIN; MESSENGER RNA; PROTEIN RHCG; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CELL MEMBRANE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DATA BASE; DOWN REGULATION; EPITHELIUM CELL; ERYTHROCYTE; ESOPHAGUS CARCINOMA; ESOPHAGUS MUCOSA; EXON; FEMALE; FRAMESHIFT MUTATION; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC STRAIN; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY; MALE; MOUTH CAVITY; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; SKIN; SQUAMOUS CELL CARCINOMA; SQUAMOUS EPITHELIUM; UTERINE CERVIX; WESTERN BLOTTING;

AMINO ACID SEQUENCE; BLOTTING, NORTHERN; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CATION TRANSPORT PROTEINS; DNA, COMPLEMENTARY; DOWN-REGULATION; ESOPHAGEAL NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE GLYCOPROTEINS; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; TUMOR CELLS, CULTURED;

EID: 0036710210     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(02)00190-9     Document Type: Article

References (30)

1. Day NE, Munoz N. Esophagus. In Cancer Epidemiology and Prevention. Schottenfeld D, Fraumeni JF, Jr. W. B. Saunders Company, Philadelphia, 1982, 596-623.
2. Lu S.H., Ohshima H., Fu H.M.et al. Urinary excretion of N-nitrosamino acids and nitrate by inhabitants of the high and low-risk areas for esophageal cancer in North China: endogenous formation of nitrosoproline and its inhibition by vitamin C. Cancer Res. 46:1986;1485-1491.
3. Li J.Y., Taylor P.R., Li B.et al. Nutrition intervention trials in Lixian, China: multiple vitamine/mineral supplementation, cancer incidence and disease-specific mortality among adults with esophageal dysplasia. J. Natl. Cancer Inst. 85:1993;1492-1498.
4. Hu N., Dawsey S.M., Wu M.et al. Familial aggregation of esophageal cancer in Yangcheng county, Shanxi province, China. Int. Epidemiol. Assoc. 21:1992;817-822.
5. Carter C.L., Hu N., Wu M., Lin P.Z., Murigande C., Bonney G.E. Segregation analysis of esophageal cancer in 221 high-risk Chinese families. J. Natl. Cancer Inst. 84:1992;771-776.
6. Li W.D., Wang X.Q., Zhang C.et al. Genetic epidemiology investigation of esophageal cancer in Yangchuan, Shanxi province. Chin. J. Med. 78:1998;203-206.
7. Xu Z.X., Wang M.R., Xu X.et al. MAL gene is down-regulated dramatically in human esophageal cancer. Chin. J. Oncol. 21:1999;250-252.
8. Wu K.M., Xu Z.X., Wang M.R.et al. Cloning and expression analysis of down-regulated cDNA C6-2A in human esophageal cancer. Chin. J. Med. Gene. 16:1999;325-327.
9. Chen B.S., Wang M.R., Cai Y.et al. Dcreased expression of SPRR3 in Chinese human oesophageal cancer. Carcinogenesis. 21:2000;2147-2150.
10. Chen B.S., Wang M.R., Xu X.et al. Transglutaminase-3, an esophageal cancer-related gene. Int J. Cancer. 88:2000;862-865.
11. Liu Z., Chen Y., Mo R.et al. Characterization of human RhCG and mouse Rhcg as novel nonerythroid Rh glycoprotein homologues predominantly expressed in kidney and testis. J. Biol. Chem. 275:2000;25641-25651.
12. Cherif-Zahar B., Matassi G., Raynal V.et al. Rh-dificiency of the regulator type caused by splicing mutations in the human RH50 gene. Blood. 92:1998a;2535-2540.
13. null blood donor of the regulator type. Blood. 91:1998;1458-1463.
14. null disease. J. Biol. Chem. 273:1998a;2207-2213.
15. null disease: the amorph type results from a novel double mutation in RhCE gene on D-negative background. Blood. 92:1998b;664-671.
16. null disease. a silent splice donor is trans to a Gly279→Glu missense mutation in the conserved transmembrane segment Blood. 92:1998c;1776-1784.
17. Huang C.H., Cheng G.J., Reid M.E., Chen Y. Rhmod syndrome. a family study of the translation-initiator mutation in the Rh50 glycoprotein gene Am. J. Hum. Genet. 64:1999;108-117.
18. Nash R., Shojania A.M. Hematological aspect of Rh deficiency syndrome. a case report and a review of the literature Am. J. Hematol. 24:1987;267-275.
19. Avent N.D., Reid M.E. The Rh blood group system. a review Blood. 1995:2000;375-387.
20. Wilson R., Ainscough R., Anderson K.et al. 2.2Mb of contiguous nucleotide sequence from chromosome III of C. elegans. Nature. 368:1994;32-38.
21. Seack J., Pancer Z., Muller I.M., Muller W.E. Molecular cloning and primary structure of a Rhesus (Rh)-like protein from the marine sponge Geodia cydonium. Immunogenetics. 46:1997;493-498.
22. Wang X.Q., Xiao F., Wang M.R., Zhou C.N., Wu M. Establishment and chromosome analysis of two human esophageal cancer cell lines. Chin. J. Oncol. 20:1998;354-356.
23. Xiao F., Wang X., Wang M.R., Guan X.Y., Wu M. Molecular cytogenetic study on four human esophageal cancer cell lines. Chin. J. Med. Genet. 15:1998;75-77.
24. Simon H.G., Oppenheimer S. Advanced mRNA differential display: isolation of a new differential regulated myosin heavy chain-encoding gene in amphibian limb regeneration. Gene. 172:1996;175-181.
25. Zhu D., Wang L., Wu M. Screening for point mutations of p53 gene in esophageal cancer by PCR-SSCP silver staining method. Chin. J. Med. Genet. 11:1994;354-355.
26. Lu S.H., Ohshima H., Fu H.M.et al. Urinary excretion of N-notrosamino acids and nitrate by inhabitants of the high and low-risk areas for esophageal cancer in North China. endogenous formation of nitrosoproline and its inhibition by vitamin C Cancer Res. 46:1986;1485-1491.
27. Li J.Y., Taylor P.R., Li B.et al. Nutrition intervention trials in Lixian, China. multiple vitamine/mineral supplementation, cancer incidence and disease-specific mortality among adults with esophageal dysplasia J. Natl. Cancer Inst. 85:1993;1492-1498.
28. Reid M.E., Bird G.W. Associations between human red cell blood group antigens and disease. Transfus. Med. Rev. 4:1990;47-55.
29. Westhoff C.M., Ferreri-Jacobia M., Mak D.O., Foskett J.K. Identification of the erythrocyte Rh-blood group glycoprotein as a mammalian ammonium transporter. J. Biol. Chem. 277:2002;12249-12502.
30. 4+ transporters. Trends Biochem. Sci. 22:1997;460-461.